α-1,6-Fucosyltransferase (α1,6FucT) is involved in the biosynthesis of asparagine-linked glycoprotein oligosaccharides. In this study, we isolated a genomic clone for the human α1,6FucT gene (FUT8) and mapped it by fluorescence in situ hybridization to chromosome 14q24.3. This study suggests a distinct localization of FUT8 from genes for other human fucosyltransferases reported to date.

1.
Aoyagi Y, Suzuki Y, Igarashi K, Yokota T, Mori S, Suda T, Naitoh A, Isemura M, Asakura H: Highly enhanced fucosylation of α-fetoprotein in patients with germ cell tumor. Cancer 72:615–618 (1993).
2.
Costache M, Apoil P-A, Cailleau A, Elmgren A, Larson G, Henry S, Blancher A, Iordachescu D, Oriol R, Mollicone R: Evolution of fucosyltransferase genes in vertebrates. J biol Chem 272:29721–29728 (1997).
3.
Huchinson WL, Du M-Q, Johnson PJ, Williams R: Fucosyltransferase: differential plasma and tissue alterations in hepatocellular carcinoma and cirrhosis. Hepatology 13:683–688 (1991).
4.
Koscielak J, Pacuszka T, Kubin J, Zdziechowska H: Serum α-6-L-fucosyltransferase is released from platelets during clotting of blood. Glycoconjugate J 4:43–49 (1987).
5.
Lamerz R: AFP isoforms and their clinical significance (overview). Anticancer Res 17:2927–2930 (1997).
6.
Miyoshi E, Uozumi N, Noda K, Hayashi N, Hori M, Taniguchi N: Expression of α1-6fucosyltransferase in rat tissues and human cancer cell lines. Int J Cancer 72:1117–1121 (1997).
7.
Noda K, Miyoshi E, Uozumi N, Gao C-X, Suzuki K, Hayashi N, Hori M, Taniguchi N: High expression of α1-6fucosyltransferase during rat hepatocarcinogenesis. Int J Cancer 75:1–7 (1997).
8.
Ohno M, Nishikawa A, Kouketsu M, Taga H, Endo Y, Hada T, Higashino K, Taniguchi N: Enzymatic basis of sugar structures of α-fetoprotein in hepatoma and hepatoblastoma cell lines: correlation with activities of α1-6fucosyltransferase and N- acetylglucosaminyltransferases III and V. Int J Cancer 51:315–317 (1992).
9.
Ohta T, Thoma T, Soejima H, Fukushima Y, Nagai T, Yoshiura K, Jinno Y, Niikawa N: The origin of cytologically unidentifiable chromosome abnormalities: six cases ascertained by targeted chromosome-band painting. Hum Genet 92:1–5 (1993).
10.
Reguigne-Arnould I, Couillin P, Mollicone R, Faure S, Fletcher A, Kelly RJ, Lowe JB, Oriol R: Relative positions of two clusters of human α-L-fucosyltransferases in 19q (FUT1-FUT2) and 19p (FUT6-FUT3-FUT5) within the microsatellite genetic map of chromosome 19. Cytogenet Cell Genet 71:158–162 (1995).
11.
Sasaki K, Kurata K, Funayama K, Nagata M, Watanabe E, Ohta S, Hanai N, Nishi T: Expression cloning of a novel α1,3-fucosyltransferase that is involved in biosynthesis of the sialyl Lewis x carbohydrate determinants in leukocytes. J biol Chem 269:14730–14737 (1994).
12.
Uozumi N, Yanagidani S, Miyoshi E, Ihara Y, Sakuma T, Gao C-X, Teshima T, Fujii S, Shiba T, Taniguchi N: Purification and cDNA cloning of porcine brain GDP-L-Fuc:N- acetyl-β-D-glucosaminide α1-6fucosyltransferase. J biol Chem 271:27810–27817 (1996).
13.
Yanagidani S, Uozumi N, Ihara Y, Miyoshi E, Yamaguchi N, Taniguchi N: Purification and cDNA cloning of GDP-L-Fuc:N- acetyl-β-D-glucosaminide α1-6fucosyltransferase (α1-6FucT) from human gastric cancer MKN45 cells. J Biochem 121:626–632 (1997).
1999
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.